Immunic market cap

WitrynaImmunic (IMUX) - Net assets Net assets on the balance sheet as of December 2024 : $0.11 B. According to Immunic's latest financial reports the company has $0.11 B in … Witryna10 godz. temu · Mark Mobius, seasoned investor and founder of Mobius Capital, believes that the concerns around the Indian ports-to-energy conglomerate Adani Group were overblown by Hindenburg Research, the ...

Immunic, Inc. Announces Closing of $103.5 Million Public Offering ...

WitrynaImmunic, cost to borrow history and number of IMUX shares available to borrow. companies: 7,324 total market cap: $87.045 T. Global ranking; Ranking by countries. … WitrynaMarket Cap. $59.1M. Currency in USD. Quote data delayed by at least 15 minutes. Immunic, Inc. 1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 332 2559811 Email: [email protected]. Immunic AG. Lochhamer Schlag 21 82166 Gräfelfing Germany Phone: +49 89 2080 477 00 Email: [email protected]. portrush self catering accommodation https://detailxpertspugetsound.com

Germany: EIB provides Immunic with up to €24.5 million to …

Witryna12 kwi 2024 · Companies. Finance. Industry Witryna11 godz. temu · The Middle East is the ‘nexus’ of energy and real estate capital markets, says venture capital firm. 02:44. ‘Really elevated’ risk of a U.S. recession at the end of this year, says ... WitrynaImmunic started at outperform with $40 stock price target at BMO Capital Jul. 20, 2024 at 8:37 a.m. ET by Tomi Kilgore Immunic started at outperform with $59 stock price target at Wedbush portrush sea swim

Immunic (IMUX) - Cost to borrow

Category:Immunic (IMUX) Stock Price & Analysis - TipRanks

Tags:Immunic market cap

Immunic market cap

Witryna10 paź 2024 · NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX) ("Immunic" or the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology ... Witryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. News provided by. Immunic, Inc. Nov 03, 2024, 06:30 ET. – $72.8 Million in Cash and Cash Equivalents as ...

Immunic market cap

Did you know?

Witryna23 godz. temu · View Immunic, Inc IMUX investment & stock information. Get the latest Immunic, Inc IMUX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... Market Cap 61.28 M Dividend 0. ... Witryna7 sty 2024 · Vital Therapies and Immunic will host a conference call at 8:00 a.m. ET on January 7, to discuss the proposed transaction. The conference call may be accessed by dialing +1 (855) 765-5682 for U.S ...

WitrynaImmunic (IMUX) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Enterprise Value/Market Cap N/A. Enterprise Value/Revenue N/A. Enterprise Value/Gross Profit-10.00T> Enterprise Value/Ebitda 0.53. Forecast. 1Y Price Target. … WitrynaInvista em Immunic, NASDAQ: IMUX Ação - Veja o preçário IMUX em tempo real. Comissões grátis online em investimentos em Immunic: compra ou venda Immunic Ação sem custos de comissão com a Trading 212. Tal como com qualquer investimento, o seu capital está em risco. Os investimentos podem cair e subir e poderá obter um …

Witryna6 kwi 2024 · Immunic, Inc. meldet Ergebnis für das am 31. Dezember 2024 beendete Geschäftsjahr. 22.02. Immunic, Inc. ist ein biopharmazeutisches Unternehmen im klinischen Stadium mit einer Pipeline von selektiven oralen Immunologie-Therapien, die sich auf die Behandlung von chronischen Entzündungs- und … WitrynaChardan Capital Markets: Buy: $40: Show Previous Ratings Apr-13-23 08:00AM: Immunic gets a "positive surprise" from lead asset trial. News Direct. Apr-06-23 02:10PM: Immunic's (IMUX) Ulcerative Colitis Study Shows Positive Data ... Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral …

Witryna20 mar 2024 · What is Immunic's Market Cap? ( NASDAQ: IMUX) Immunic 's market cap is $74.15M, as of Mar 22, 2024. Market cap (market capitalization) is the total …

WitrynaImmunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule … portrush street mapWitrynaContact Email [email protected]. Phone Number +4989208047700. Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products; its lead development program, … optum and lhcWitrynaAs of February 2024 Immunic's TTM earnings are -$83.89 M. companies: 7,303 total market cap: $84.738 T. Global ranking; Ranking by countries. America ... The … optum and uhgWitrynaMarket Cap is a widely used stock evaluation measure. Find the latest Market Cap for Immunic (IMUX) optum and united healthWitrynaFind the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 61.277M: Beta (5Y Monthly) 1.70: PE ... portrush stoneWitryna12 kwi 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol "IMUX" on April 15, 2024. Immunic, Inc. is a ... optum and united healthcare partnershipWitryna12 kwi 2024 · SVB Securities Reaffirms Their Hold Rating on Immunic (IMUX) markets.businessinsider.com - November 21 at 10:04 AM: Immunic, Inc. (IMUX) Q3 2024 Earnings Call Transcript seekingalpha.com - November 6 at 5:38 AM: Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update … portrush rentals